African-Canadian Study of HIV-Infected Adults and a Vaccine for Ebola - ACHIV-Ebola
Phase 2
Active, not recruiting
- Conditions
- Ebola
- Interventions
- Biological: V920 (rVSVΔG-ZEBOV-GP) Ebola Virus VaccineOther: Saline
- First Posted Date
- 2017-01-26
- Last Posted Date
- 2024-08-27
- Lead Sponsor
- Cecile Tremblay
- Target Recruit Count
- 250
- Registration Number
- NCT03031912
- Locations
- 🇨🇦
CHUM, Montréal, Quebec, Canada
© Copyright 2025. All Rights Reserved by MedPath